Why do we eat? A neural systems approach

Annual Review of Nutrition

Volumn 17, Issue , 1997, Pages 597-619

  Levine, Allen S ^a   Billington, Charles J ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Brain nuclei; Corticotropin releasing hormone; Energy; Networks; Neuropeptide Y; Opioids

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; NEUROPEPTIDE Y; OPIATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BINDING SITE; BRAIN NUCLEUS; ENERGY METABOLISM; ENZYME ACTIVITY; FEEDING; FEEDING DISORDER; LIPID STORAGE; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; EATING; ENERGY METABOLISM; HUMANS; NERVOUS SYSTEM PHYSIOLOGY; NEUROPEPTIDE Y; NEUROTRANSMITTER AGENTS; STRESS;

ANIMALIA;

EID: 0030795283     PISSN: 01999885     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.nutr.17.1.597     Document Type: Review

References (139)

1. Akabayashi A, Watanabe Y, Wahlestedt C, McEwen BS, Paez X, Leibowitz SF. 1994. Hypothalamic neuropeptide Y, its gene expression and receptor activity: relation to circulating corticosterone in adrenalectomized rats. Brain Res. 665:201-12
2. Akil H, Watson SJ, Young E, Lewis ME, Khachaturian H, Walker JM. 1984. Endogenous opioids: biology and function. Annu. Rev. Neurosci. 7:223-55
3. Arjune D, Bowen WD, Bodnar RJ. 1991. Ingestive behavior following central [D-Ala2, Leu5, Cys6]-enkephalin (DALCE), a short-acting agonist and long-acting antagonist at the delta opioid receptor. Pharmacol. Biochem. Behav. 39:429-36
4. Arjune D, Standifer KM, Pasternak GW, Bodnar RJ. 1990. Reduction by central beta-funaltrexamine of food intake in rats under freely-feeding, deprivation and glucoprivic conditions. Brain Res. 535:101-9
5. Bartness TJ, Warren WS, Adkinson MG. 1996. Sympathetic nervous system innervation of white adipose tissue: from the hypothalamus to the fat pad. Obes. Res. 4:S63
6. Bergmann F, Lieblich I, Cohen E, Ganchrow JR. 1985. Influence of intake of sweet solutions on the analgesic effect of a low dose of morphine in randomly bred rats. Behav. Neural Biol. 44:347-53
7. Berman Y, Devi L, Carr KD. 1994. Effects of chronic food restriction on prodynorphin-derived peptides in rat brain regions. Brain Res. 664:49-53
8. Berman Y, Devi L, Carr KD. 1995. Effects of streptozotocin-induced diabetes on prodynorphin-derived peptides in rat brain regions. Brain Res. 685:129-34
9. BertinoM, Beauchamp GK, Engelman K. 1991. Naltrexone, an opioid blocker, alters taste perception and nutrient intake in humans. Am. J. Physiol. 261:R59-R63
10. Billington CJ, Briggs JE, Grace M, Levine AS. 1991. Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism. Am. J. Physiol. 260:R321-27
11. Billington CJ, Briggs JE, Harker S, Grace M, Levine AS. 1994. Neuropeptide Y in hypothalamic paraventricular nucleus: a center coordinating energy metabolism. Am. J. Physiol. 266:R1765-70
12. Billington CJ, Levine AS. 1996. Appetite regulation: shedding new light on obesity. Curr. Biol. 6:920-23
13. Blass E, Fitzgerald E, Kehoe P. 1987. Interactions between sucrose, pain and isolation distress. Pharmacol. Biochem. Behav. 26:483-89
14. Bodnar RK. 1996. Opioid receptor subtype antagonist and ingestion. In Opioid Receptor Subtype Antagonist and Ingestion, ed. SJ Cooper, PG Clifton, pp. 127-46. London: Academic
15. Bossone CA, Hannon JP. 1991. Metabolic actions of morphine in conscious cronically instrumented pigs. Am. J. Physiol. 29:R1051-57
16. Brady LS, Smith MA, Gold PW, Herkenham M. 1990. Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food-deprived rats. Neuroendocrinology 52:441-47
17. Brennan G, Bachus SE, Jhanwar-Uniyal M. 1994. Involvement of gene expression for hypothalamic dynorphin in dietary preference. J. Neurosci. 20:818
18. Britton DR, Indyk E. 1989. Effects of ganglionic blocking agents on behavioral responses to centrally administered CRF. Brain Res. 478:205-10
19. Britton DR, Koob GF, Rivier J, Vale W. 1982. Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty. Life Sci. 31:363-67
20. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. 1995. Recombinant Mouse OB Protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269:546-47
21. Carr KD. 1984. The physiology of opiate hedonic effects and the role of opioids in motivated behavior. Adv. Alcohol Subst. Abuse 3:5-18
22. Carr KD. 1996. Opioid receptor subtypes and stimulation-induced feeding. In Opioid Receptor Subtypes and Stimulation-Induced Feeding, ed. SJ Cooper, PG Clifton, pp. 167-92. London: Academic
23. Carr KD, Simon EJ. 1983. Effects of naloxone and its quaternary analogue on stimulation-induced feeding. Neuropharmacology 22:127-30
24. Carr KD, Simon EJ. 1983. The role of opioids in feeding and reward elicited by lateral hypothalamic electrical stimulation. Life Sci. 1:563-66
25. Carr KD, Simon EJ. 1984. Potentiation of reward by hunger is opioid mediated. Brain Res. 297:369-73
26. Chua S Jr, Brown AW, Kim J, Hennessey KL, Leibel RL, Hirsch J. 1991. Food deprivation and hypothalamic neuropeptide gene expression: effects of strain background and the diabetes mutation. Brain Res. Mol. Brain Res. 11:291-99
27. Clark JT, Kalra PS, Crowley WR, Kalra SP. 1984. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology 115:427-29
28. Cooper SJ, Jackson A, Kirkham TC, Turkish S. 1988. Endorphins, opiates and food intake. In Endorphins, Opiates and Food Intake, ed. RJ Rodgers, SJ Cooper, pp. 143-86. London: Wiley & Sons
29. Corder R, Pralong F, Turnill D, Saudan P, Muller AF, Gaillard RC. 1988. Dexamethasone treatment increases neuropeptide Y levels in rat hypothalamic neurons. Life Sci. 43:1879-86
30. Davies L, Marks JL. 1994. Role of hypothalamic neuropeptide Y gene expression in body weight regulation. Am. J. Physiol. 266:R1687-91
31. Dean RG, White BD. 1990. Neuropeptide Y expression in rat brain: effects of adrenalectomy. Neurosci. Lett. 114:339-44
32. Drewnowski A, Krahn DD, Demitrack MA, Nairn K, Gosnell BA. 1992. Taste responses and preferences for sweet high-fat foods: evidence for opioid involvement. Physiol. Behav. 51:371-79
33. Dube MG, Sahu A, Kalra PS, Kalra SP. 1992. Neuropeptide Y release is elevated from the microdissected paraventricular nucleus of food-deprived rats: an in vitro study. Endocrinology 131:684-88
34. Dum J, Gramsch C, Herz A. 1983. Activation of hypothalamic beta-endorphin pools by reward induced by highly palatable food. Pharmacol. Biochem. Behav. 18:443-47
35. Egawa M, Yoshimatsu H, Bray GA. 1991. Neuropeptide Y suppresses sympathetic activity to interscapular brown adipose tissue in rats. Am. J. Physiol. 260:R328-34
36. Egawa M, Yoshimatsu H, Bray GA. 1993. Effect of ß-endorphin on sympathetic nerve activity to interscapular brown adipose tissue. Am. J. Physiol. 264:R109-15
37. Fantino M, Hosotte J, Apfelbaum M. 1986. An opioid antagonist, naltrexone, reduces preference for sucrose in humans. Am. J. Physiol. 251:R91-R96
38. Farrell PA, Gates WK, Maksud MG, Morgan WP. 1982. Increases in plasma beta-endorphin/beta-lipptropin immunoreactivity after treadmill running in humans. J. Appl. Physiol. 52:1245-49
39. Glass MJ, Grace M, Cleary JP, Billington CJ, Levine AS. 1996. Potency of naloxone's anorectic effect in rats is dependent on diet preference. Am. J. Physiol. 271:R217-21
40. Grandison L, Guidotti A. 1977. Stimulation of food intake by muscimol and beta endorphin. Neuropharmacology 16:533-36
41. Greenberg BR. 1986. Predictors of binge eating in bulimic and nonbulimic women. Int. J. Eating Disord. 5:269-84
42. Gunion MW, Peters RH. 1981. Pituitary beta-endorphin, naloxone, and feeding in several experimental obesities. Am. J. Physiol 241:R173-84
43. Gunion MW, Rosentahl MJ, Morley JE, Miller S, Zib B, et al. 1991. μ-Receptor mediates elevated glucose and corticosterone after third ventricle injection of opioid peptides. Am. J. Physiol. 261:R60-R81
44. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, et al. 1995. Weight-reducing effect of the plasma protein encoded by the obese gene. Science 269: 543-46
45. Harri M, Kuusela P. 1986. Is swimming exercise or cold exposure for rats? Acta Physiol. Scand. 126:189-97
46. Heilig M, McLeod S, Koob GK, Britton KT. 1992. Anxiolytic-like effect of neuropeptide Y (NPY), but not other peptides in an operant conflict test. Regul. Pept. 41:61-69
47. Heilig M, Widerlov E. 1995. Neurobiology and clinical aspects of neuropeptide Y. Crit. Rev. Neurobiol. 9:115-36
48. Heinrichs SC, Cole BJ, Pich EM, Menzaghi F, Koob GF, Hauger RL. 1992. Endogenous corticotropin-releasing factor modulates feeding induced by neuropeptide Y or a tail-pinch Stressor. Peptides 13:879-84
49. Heinrichs SC, Koob GF. 1992. Corticotropin-releasing factor modulates dietary preference in nutritionally and physically stressed rats. Psychopharmacology 109:177-84
50. Hulsey MG, Pless CM, Martin RJ. 1995. ICV administration of anti-corticotropin-releasing factor antisense oligonucleotide: effects on feeding behavior and body weight. Regul. Pept. 59:241-46
51. Jewett DC, Cleary J, Levine AS, Schaal DW, Thompson T. 1992. Effects of neuropeptide Y on food-reinforced behavior in satiated rats. Pharmacol. Biochem. Behav. 42:207-12
52. Jewett DC, Cleary J, Levine AS, Schaal DW, Thompson T. 1995. Effects of neuropeptide Y, insulin, 2-deoxyglucose, and food deprivation on food-motivated behavior. Psychopharmacology 120:267-71
53. Jewett DC, Schaal DW, Cleary J, Thompson T, Levine AS. 1991. The discriminative stimulus effects of neuropeptide Y. Brain Res. 561:165-68
54. Kalra SP, Dube MG, Sahu A, Phelps CP, Kalra PS. 1991. Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proc. Natl. Acad. Sci. USA 88:10931-35
55. Kaye WH, Gwirtsman HE, George DT, Weiss SR, Jimerson DC. 1986. Relationship of mood alterations to bingeing behaviour in bulimia. Br. J. Psychiatry 149:479-85
56. Kehoe P, Blass EM. 1986. Opioidmediation of separation distress in 10-day-old rats: reversal of stress with maternal stimuli. Dev. Psychobiol. 19:385-98
57. Kim E, Welch CC, Grace MK, Billington CJ, Levine AS. 1996. Chronic food restriction and acute food deprivation decrease mRNA levels of opioid peptides in arcuate nucleus. Am. J. Physiol. 270:R1019-24
58. Kirchgessner AL, Sclafani A. 1988. PVN-hindbrain pathway involved in the hypothalamic hyperphagia-obesity syndrome. Physiol. Behav. 42:517-28
59. Kirkham TC, Blundell JE. 1984. Dual action of naloxone on feeding revealed by behavioural analysis: separate effects on initiation and termination of eating. Appetite 5:45-52
60. Kirkham TC, Blundell JE. 1986. Effect of naloxone and naltrexone on the development of satiation measured in the runway: comparisons with d-amphetamine and d-fenfluramine. Pharmacol. Biochem. Behav. 25:123-28
61. Kirkham TC, Blundell JE. 1987. Effects of naloxone and naltrexone on meal patterns of freely-feeding rats. Pharmacol. Biochem. Behav. 26:515-20
62. Kirkham TC, Cooper SJ. 1988. Naloxone attenuation of sham feeding is modified by manipulation of sucrose concentration. Physiol. Behav. 44:491-94
63. Kotz CM, Grace MK, Briggs JE, Levine AS, Billington CJ. 1995. Effect of opioid antagonists naloxone and naltrexone on neuropeptide Y-induced feeding and brown fat thermogenesis in the rat: neural site of action. J. Clin. Invest. 96:163-70
64. Krahn DD, Gosnell BA, Grace M, Levine AS. 1986. CRF antagonist partially reverses CRF- and stress-induced effects on feeding. Brain Res. Bull. 17:285-89
65. Krahn DD, Gosnell BA, Levine AS, Morley JE. 1988. Behavioral effects of corticotropin-releasing factor: localization and characterization of central effects. Brain Res. 443:63-69
66. Lefer L. 1971. Psychic stress and the oral cavity. Postgrad. Med. 49:171-75
67. Leibowitz SF. 1991. Brain neuropeptide Y: an integrator of endocrine, metabolic and behavioral processes. Brain Res. Bull. 27:333-37
68. Leibowitz SF. 1994. Specificity of hypothalamic peptides in the control of behavioral and physiological processes. Ann. NY Acad. Sci. 739:12-35
69. Levin BE. 1995. Reduced norepinephrine turnover in organs and brains of obesityprone rats. Am. J. Physiol. 268:R389-94
70. Levine AS, Billington CJ. 1991. Stress and feeding behavior. Clin. Appl. Nutr. 1:33-41
71. Levine AS, Billington CJ. 1996. Peptides in regulation of energy metabolism and body weight. In Peptides in Regulation of Energy Metabolism and Body Weight, ed. C Bouchard, GA Bray, pp. 180-91. London: Wiley & Sons
72. Levine AS, Grace M, Billington CJ. 1991. Beta-funaltrexamine (beta-FNA) decreases deprivation and opioid-induced feeding. Brain Res. 562:281-84
73. Levine AS, Grace M, Billington CJ, Portoghese PS. 1990. Nor-binaltorphimine decreases deprivation and opioid-induced feeding. Brain Res. 534:60-64
74. Levine AS, Kuskowski MA, Grace M, Billington CJ. 1991. Food deprivation-induced vs. drug-induced feeding: a behavioral evaluation. Am. J. Physiol. 260: R546-52
75. Levine AS, Morley JE. 1981. Peptidergic control of insulin-induced feeding. Peptides 2:261-64
76. Levine AS, Morley JE. 1984. Neuropeptide Y: a potent inducer of consummatory behavior in rats. Peptides 5:1025-29
77. Levine AS, Morley JE, Gosnell BA, Billington CJ, Bartness TJ. 1985. Opioids and consummatory behavior. Brain Res. Bull. 14:663-72
78. Levine AS, Morley JE, Raij L. 1986. Opiates and the anorexia of uremia. Physiol. Behav. 37:835-38
79. Levine AS, Murray SS, Kneip J, Grace M, Morley JE. 1982. Flavor enhances the antidipsogenic effect of naloxone. Physiol. Behav. 28:23-25
80. Levine AS, Rogers B, Kneip J, Grace M, Morley JE. 1983. Effect of centrally administered corticotropin releasing factor (CRF) on multiple feeding paradigms. Neuropharmacology 22:337-39
81. Levine AS, Weldon DT, Grace M, Cleary JP, Billington CJ. 1995. Naloxone blocks that portion of feeding driven by sweet taste in food-restricted rats. Am. J. Physiol. 268:R248-52
82. Lewis DE, Shellard L, Koeslag DG, Boer DE, McCarthy HD, et al. 1993. Intense exercise and food restriction cause similar hypothalamic neuropeptide Y increases in rats. Am. Physiol. 264:E279-84
83. Lowy MT, Maickel RP, Yim GK. 1980. Naloxone reduction of stress-related feeding. Life Sci. 26:2113-18
84. Lynch WC. 1986. Opiate blockade inhibits saccharin intake and blocks normal preference acquisition. Pharmacol. Biochem. Behav. 24:833-36
85. Lynch WC, Grace M, Billington CJ, Levine AS. 1993. Effects of neuropeptide Y on ingestion of flavored solutions in nondeprived rats. Physiol. Behav. 54:877-80
86. Lynch WC, Hart P, Babcock AM. 1994. Neuropeptide Y attenuates satiety: evidence from a detailed analysis of patterns ingestion. Brain Res. 636:28-34
87. Malabu UH, Kilpatrick A, Ware M, Vernon RG, Williams G. 1994. Increased neuropeptide Y concentrations in specific hypothalamic regions of lactating rats: possible relationship to hyperphagia and adaptive changes in energy balance. Peptides 15:83-87
88. Mansour A, Fox CA, Akil H, Watson SJ. 1995. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 18:22-29
89. Martin WR, Wilder A, Eades CG, Pescor FT. 1963. Tolerance to and physical dependence on morphine in rats. Psychopharmacologia 4:247-60
90. Menzaghi F, Heinrichs SC, Pich EM, Tilders FJ, Koob GF. 1993. Functional impairment of hypothalamic corticotropin-releasing factor neurons with immuno-targeted toxins enhances food intake induced by neuropeptide Y. Brain Res. 618: 76-82
91. Miller DS, Mumford P, Stock MJ. 1967. Gluttony: thermogenesis in overeating man. Am. J. Clin. Nutr. 20:1223-29
92. Miller TW, Feibelman ND. 1989. Traumatic stress disorder: diagnostic and clinical issues in psychiatry. In Traumatic Stress Disorder: Diagnostic and Clinical Issues in Psychiatry, ed. TW Miller, pp. 553-71. Madison: Int. Univ. Press
93. Morien A, Wellman PJ, Fojt J. 1995. Diurnal rhythms of paraventricular hypothalamic norepinephrine and food intake in rats. Pharmacol. Biochem. Behav. 52:169-74
94. Morley JE. 1983. Neuroendocrine effects of endogenous opioid peptides in human subjects: a review. Psychoneuroendocrinology 8:361-79
95. Morley JE. 1990. Appetite regulation by gut peptides. Annu. Rev. Nutr. 10:383-95
96. Morley JE, Levine AS. 1980. Stress-induced eating is mediated through endogenous opiates. Science 209:1259-61
97. Morley JE, Levine AS. 1982. Corticotropin releasing factor, grooming and ingestive behavior. Life Sci. 31:1459-64
98. Morley JE, Levine AS, Gosnell BA, Kneip J, Grace M. 1987. Effect of neuropeptide Y on ingestive behaviors in the rat. Am. J. Physiol. 252:R599-609
99. O'Hare E, Cleary J, Billington CJ, Levine AS. 1996. Naloxone administration following operant training of sucrose/water discrimination in the rat. Psychopharmacology. In press
100. Ostrowski NL, Rowland N, Foley TL, Nelson JL, Reid LD. 1981. Morphine antagonists and consummatory behaviors. Pharmacol. Biochem. Behav. 14:549-59
101. Parker LA, Maier S, Rennie M, Crebolder J. 1992. Morphine-and naltrexone-induced modification of palatability: analysis by the taste reactivity test. Behav. Neurosci. 106:999-1010
102. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, et al. 1995. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269:540-42
103. Rainer K, Reinscheid RK, Nothacker HP, Bourson A, Ardati A, et al. 1995. Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science 270:792-94
104. Reid LD. 1985. Endogenous opioid peptides and regulation of drinking and feeding. Am. J. Clin. Nutr. 42:1099-132
105. Rockwood GA, Reid LD. 1982. Naloxone modifies sugar-water intake in rats drinking with open gastric fistulas. Physiol. Behav. 29:1175-78
106. Rothwell NJ, Stock MJ, Warwick BP. 1985. Energy balance and brown fat activity in rats fed cafeteria diets or high-fat, semisynthetic diets at several levels of intake. Metabolism 34:474-80
107. Rudski JM, Thomas D, Billington CJ, Levine AS. 1995. Buprenorphine increases intake of freely available and operant-contingent food in satiated rats. Pharmacol. Biochem. Behav. 50:271-76
108. Sahu A, Kalra PS, Kalra SP. 1988. Food deprivation and ingestion induce reciprocal changes in neuropeptide Y concentrations in the paraventricular nucleus. Peptides 9:83-86
109. Sayetta RB. 1986. Pica: an overview. Am. Fam. Physician. 33:181-85
110. Schwartz MW, Figlewicz DP, Woods SC, Porte D Jr, Baskin DG. 1993. Insulin, neuropeptide Y, and food intake. Ann. NY Acad. Sci. 692:60-71
111. Seegmiller JE. 1980. Diseases of purine and pyrimidine metabolism. In Diseases of Purine and Pyrimidine Metabolism, ed. PK Bondy, LE Rosenberg, pp. 877-937. Philadelphia: Saunders
112. Seeley RJ, Benoit SC, Davidson TL. 1995. Discriminative cues produced by NPY do not generalize to the interoceptive cues produced by food deprivation. Physiol. Behav. 58:1237-41
113. Seeley RJ, Payne CJ, Woods SC. 1995. Neuropeptide Y fails to increase intraoral intake in rats. Am. J. Physiol. 268:R423-27
114. Shaw NS, Rutherdale M, Kenny J. 1985. Eating more and enjoying it less: U. S. prison diets for women. Women. Health 10:39-57
115. Shibasaki T, Yamauchi N, Kato Y, Masuda A, Imaki T, et al. 1988. Involvement of corticotropin-releasing factor in restraint stress-induced anorexia and reversion of the anorexia by somatostatin in the rat. Life Sci. 43:1103-10
116. Shide DJ, Blass EM. 1991. Opioid mediation of odor preferences induced by sugar and fat in 6-day-old rats. Physiol. Behav. 50:961-66
117. Sims EAH, Goldman RF, Gluck CM, Horton ES, Kelleher PC, Rowe DW. 1968. Experimental obesity in man. Trans. Am. Assoc. Phys. 81:153-60
118. Singhi P, Singhi S. 1983. Nutritional status and psycho-social stress in children with pica. Indian Pediatr. 20:345-49
119. Sipols AJ, Brief DJ, Ginter KL, Saghafi S, Woods SC. 1992. Neuropeptide Y paradoxically increases food intake yet causes conditioned flavor aversions. Physiol. Behav. 51:1257-60
120. Smith GP, Gibbs J. 1994. Satiating effect of cholecystokinin. Ann. NY Acad. Sci. 713:236-41
121. Smith MS. 1993. Lactation alters neuropeptide-Y and proopiomelanocortin gene expression in the arcuate nucleus of the rat. Endocrinology 133:1258-65
122. Spiess J, Rivier J, Rivier C, Vale W. 1981. Primary structure of corticotropin-releasing factor from ovine hypothalamus. Proc. Natl. Acad. Sci. USA 78:6517-21
123. Spina M, Merlo-Pich E, Chan RKW, Basso AM, Rivier J, Vale W, et al. 1996. Appetitie-suppressing effects of urocortin, a CRF-related neuropeptide. Science 273:1561-64
124. Stanley BG, Daniel DR, Chin AS, Leibowitz SF. 1985. Paraventricular nucleus injections of peptide YY and neuropeptide Y preferentially enhance carbohydrate ingestion. Peptides 6:1205-11
125. Stanley BG, Leibowitz SF. 1984. Neuropeptide Y: stimulation of feeding and drinking by injection into the paraventricular nucleus. Life Sci. 35:2635-42
126. Stephens TW, Basinski M, Bristow PK, Bue-Vallensky JM, Burgett SG, et al. 1995. The role of neuropeptide Y in the anti-obesity action of the obese gene product. Nature 377:530-32
127. Tempel DL, Leibowitz SF. 1993. Glucocorticoid receptors in PVN: interactions with NE, NPY, and Gal in relation to feeding. Am. J. Physiol. 265:E794-800
128. Tempel DL, Leibowitz SF. 1994. Adrenal steroid receptors: interactions with brain neuropeptide systems in relation to nutrient intake and metabolism. J. Neuroendocr. 6:479-501
129. Vale W, Spiess J, Rivier C, Rivier J. 1981. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213:1394-97
130. Vaswani K, Tejwani GA, Mousa S. 1983. Stress induced differential intake of various diets and water by rat: the role of the opiate system. Life Sci. 32:1983-96
131. Welch CC, Grace MK, Billington CJ, Levine AS. 1994. Preference and diet type affect macronutrient selection after morphine, NPY, norepinephrine and deprivation. Am. J. Physiol. 266:R426-33
132. Deleted in proof
133. Welch CC, Kim EM, Grace MK, Billington CJ, Levine AS. 1996. Palatability-induced hyperphagia increases hypothalamic dynorphin peptide and mRNA levels. Brain Res. 721:126-31
134. Weldon DT, O'Hare E, Cleary J, Billington CJ, Levine AS. 1996. Effect of naloxone on intake of cornstarch, sucrose and polycose diets in resticted and non-restricted rats. Am. J. Physiol 39:R1183-88
135. White BD, Dean RG, Edwards GL, Martin RJ. 1994. Type II corticosteroid receptor stimulation increases NPY gene expression in basomedial hypothalamus of rats. Am. J. Physiol. 266:R1523-29
136. White JD, Olchovsky D, Kershaw M, Berelowitz M. 1990. Increased hypothalamic content of preproneuropeptide-Y messenger ribonucleic acid in streptozotocin-diabetic rats. Endocrinology 126: 765-72
137. Wolinsky TD, Carr KD, Hiller JM, Simon EJ. 1994. Effects of chronic food restriction on mu and kappa opioid binding in rat forebrain: a quantitative autoradiographic study. Brain Res. 656:274-80
138. Yirmiya R, Lieblich I, Liebeskind JC. 1988. Reduced saccharin preference in CXBK (opioid receptor-deficient) mice. Brain Res. 438:339-42
139. Zarjevski N, Cusin I, Vettor R, Rohner-Jeanrenaud F, Jeanrenaud B. 1994. Intracerebroventricular administration of neuropeptide Y to normal rats has divergent effects on glucose utilization by adipose tissue and skeletal muscle. Diabetes 43: 764-69